• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤药物顺二氨二氯铂(II)及相关铂配合物对真核生物DNA复制的影响。

Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.

作者信息

Heiger-Bernays W J, Essigmann J M, Lippard S J

机构信息

Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139.

出版信息

Biochemistry. 1990 Sep 11;29(36):8461-6. doi: 10.1021/bi00488a037.

DOI:10.1021/bi00488a037
PMID:2174701
Abstract

An SV40-based in vitro replication system has been used to examine the effects of platinum compounds on eukaryotic DNA replication. Plasmid templates containing the SV40 origin of replication were modified with the anticancer drug cis-diamminedichloroplatinum(II) (cis-DDP, cisplatin) or the inactive analogues [Pt(dien)Cl]+ and trans-DDP. The platinated plasmids were used as templates for DNA synthesis by the DNA polymerases present in cytosolic extracts prepared from human cell lines HeLa and 293. Bifunctional adducts formed by cis- and trans-DDP inhibited DNA replication by 95% at a bound drug to nucleotide ratio [(D/N)b] of less than 9 x 10(-4), in contrast to the monofunctional [Pt(dien)Cl]+ analogues, which required a (D/N)b of 3.4 x 10(-3) for 62% inhibition of DNA replication. An average of two platinum adducts per genome was sufficient for inhibition of DNA replication by cisplatin. When trans-DDP-modified, but not cis-DDP-modified, SV40 origin containing plasmids [(D/N)b = 1.7 x 10(-3)] were allowed to incubate in the 293 cytosolic extracts for 1 h prior to addition of T-antigen to initiate replication, DNA synthesis was restored to 30% of control. This result suggested the presence of an activity in the extracts that reactivates trans-DDP-modified DNA templates for replication. This hypothesis was confirmed by an in vitro nucleotide excision repair assay that revealed activity in 293 and HeLa cell extracts selective for trans-DDP-modified plasmid DNAs. Such selective repair of trans-DDP-damaged DNA in human cells would contribute to its lack of antitumor activity.

摘要

一种基于猿猴病毒40(SV40)的体外复制系统已被用于研究铂化合物对真核生物DNA复制的影响。含有SV40复制起点的质粒模板用抗癌药物顺二氯二氨铂(II)(顺铂,cis-DDP)或无活性类似物[Pt(dien)Cl]+和反式-DDP进行修饰。这些铂化质粒被用作模板,供从人细胞系HeLa和293制备的胞质提取物中的DNA聚合酶进行DNA合成。顺铂和反式-DDP形成的双功能加合物在结合药物与核苷酸的比例[(D/N)b]小于9×10^(-4)时,可抑制DNA复制95%,相比之下,单功能的[Pt(dien)Cl]+类似物在(D/N)b为3.4×10^(-3)时,可抑制DNA复制62%。每个基因组平均两个铂加合物就足以抑制顺铂的DNA复制。当含有反式-DDP修饰而非顺铂修饰的SV40复制起点的质粒[(D/N)b = 1.7×10^(-3)]在加入T抗原启动复制之前,在293胞质提取物中孵育1小时后,DNA合成恢复到对照的30%。这一结果表明提取物中存在一种活性,可使反式-DDP修饰的DNA模板重新激活用于复制。体外核苷酸切除修复试验证实了这一假设,该试验显示293和HeLa细胞提取物中存在对反式-DDP修饰的质粒DNA具有选择性的活性。人类细胞中对反式-DDP损伤DNA的这种选择性修复将导致其缺乏抗肿瘤活性。

相似文献

1
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.抗肿瘤药物顺二氨二氯铂(II)及相关铂配合物对真核生物DNA复制的影响。
Biochemistry. 1990 Sep 11;29(36):8461-6. doi: 10.1021/bi00488a037.
2
In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication.顺式和反式二氯二氨铂(II)对SV40染色体的体内效应:差异修复、DNA-蛋白质交联及复制抑制
Biochemistry. 1985 Dec 17;24(26):7533-40. doi: 10.1021/bi00347a005.
3
DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.顺二氯二氨铂(II)及其反式异构体的DNA加合物在体内对RNA聚合酶II有不同的抑制作用。
Biochemistry. 1995 Nov 14;34(45):14783-91. doi: 10.1021/bi00045a020.
4
Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).针对经顺式或反式二氯二氨铂(II)修饰的DNA的单克隆抗体。
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8225-9. doi: 10.1073/pnas.84.23.8225.
5
Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.在含有位点特异性放置的顺二氯二氨铂(II)DNA加合物的模板上的复制抑制和跨损伤合成。
Biochemistry. 1992 Apr 28;31(16):3975-90. doi: 10.1021/bi00131a013.
6
Repair of plasmid DNA damaged in vitro with cis- or trans-diamminedichloroplatinum(II) in Escherichia coli.
Mutat Res. 1987 Mar;183(2):129-37. doi: 10.1016/0167-8817(87)90055-1.
7
Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.顺式和反式二氯二氨合铂(II)对哺乳动物细胞的差异毒性:其与DNA结合加合物丢失速率的任何差异均无影响。
Cancer Res. 1987 Jan 1;47(1):31-6.
8
Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.人细胞提取物对顺铂损伤DNA的修复合成主要由次要加合物决定。
Nucleic Acids Res. 1992 Dec 11;20(23):6363-8. doi: 10.1093/nar/20.23.6363.
9
Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies.顺式和反式二氯二氨铂(II)与脱氧核糖核酸的结合会使核苷暴露,这是通过用抗核苷抗体进行免疫化学测定的。
Biochemistry. 1986 Apr 8;25(7):1520-4. doi: 10.1021/bi00355a008.
10
DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.抗肿瘤反式-[PtCl2(NH3)(噻唑)]与DNA的结合。单功能加合物的蛋白质识别与核苷酸切除修复。
Biochemistry. 2003 Jan 28;42(3):792-800. doi: 10.1021/bi026614t.

引用本文的文献

1
Cervical cancer: a tale from HPV infection to PARP inhibitors.宫颈癌:从人乳头瘤病毒感染到聚(ADP - 核糖)聚合酶抑制剂的故事
Genes Dis. 2022 Nov 10;10(4):1445-1456. doi: 10.1016/j.gendis.2022.09.014. eCollection 2023 Jul.
2
Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity.小鼠耳蜗固有 mast 细胞脱颗粒:顺铂诱导耳毒性和神经毒性的一个可能因素。
Int J Mol Sci. 2023 Feb 27;24(5):4620. doi: 10.3390/ijms24054620.
3
Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.
NQO1的药理学激活可提高NAD⁺水平,并减轻顺铂介导的小鼠急性肾损伤。
Kidney Int. 2014 Mar;85(3):547-60. doi: 10.1038/ki.2013.330. Epub 2013 Sep 11.
4
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells.一种texaphyrin-奥沙利铂缀合物,可克服癌细胞中顺铂耐药性的药理学和分子机制。
Medchemcomm. 2012;3(10):1275-1281. doi: 10.1039/C2MD20206A.
5
Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate.用四吡咯铂缀合物克服铂耐药的生化药理学机制。
Bioorg Med Chem Lett. 2011 Mar 15;21(6):1701-5. doi: 10.1016/j.bmcl.2011.01.092. Epub 2011 Jan 26.
6
The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.抗肿瘤药物顺铂及其临床无效异构体反铂在人类细胞中产生独特的基因表达谱。
Cancer Inform. 2008;6:315-55. doi: 10.4137/cin.s802. Epub 2008 Jun 10.
7
Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.以环己胺作为旁观配体的反式铂(II)配合物通过抑制DNA合成和RNA转录诱导肿瘤细胞坏死。
Clin Transl Oncol. 2007 Aug;9(8):521-30. doi: 10.1007/s12094-007-0096-2.
8
Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.顺二氯二氨铂(II)在DNA上形成的1,2-链内交联与侧翼序列无关。
Nucleic Acids Res. 2000 Nov 1;28(21):4237-43. doi: 10.1093/nar/28.21.4237.
9
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.具有复制能力的单纯疱疹病毒载体G207与顺铂联合治疗头颈部鳞状细胞癌。
Neoplasia. 1999 Jun;1(2):162-9. doi: 10.1038/sj.neo.7900016.
10
Recognition of DNA alterations by the mismatch repair system.错配修复系统对DNA改变的识别。
Biochem J. 1999 Feb 15;338 ( Pt 1)(Pt 1):1-13.